“By mapping the global stress of drug-resistant germs and evaluating their impact on general public well being, this list is key to guiding investment decision and grappling with the antibiotics pipeline and obtain crisis," explained Dr Yukiko Nakatani, WHO’s Assistant Director-Basic for Antimicrobial Resistance advertisement interimThe BPPL 20